Clinical Trial Update: Modulating Socially Adaptive Mirror System Functioning in Autism by Oxytocin [Phase 3]

View source ↗

Summary

Phase 3 trial assessing oxytocin to modulate social functioning in autism has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Oxytocin (Oxytocin)

Snippet

Sponsor: KU Leuven | Conditions: Autism Spectrum Disorder | Phase 3 | Status: COMPLETED